CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 291 filers reported holding CONCENTRIX CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $831,120 | -4.4% | 13,134 | 0.0% | 0.06% | -8.3% |
| Q1 2024 | $869,733 | -32.6% | 13,134 | 0.0% | 0.06% | -38.8% |
| Q4 2023 | $1,289,890 | +168.4% | 13,134 | +118.9% | 0.10% | +145.0% |
| Q3 2023 | $480,660 | -0.8% | 6,000 | 0.0% | 0.04% | +2.6% |
| Q2 2023 | $484,500 | -33.6% | 6,000 | 0.0% | 0.04% | -35.0% |
| Q1 2023 | $729,300 | -8.7% | 6,000 | 0.0% | 0.06% | -10.4% |
| Q4 2022 | $798,960 | +19.2% | 6,000 | 0.0% | 0.07% | +17.5% |
| Q3 2022 | $670,000 | -58.8% | 6,000 | -50.0% | 0.06% | -55.1% |
| Q2 2022 | $1,628,000 | -18.6% | 12,000 | 0.0% | 0.13% | +4.1% |
| Q1 2022 | $1,999,000 | -6.7% | 12,000 | 0.0% | 0.12% | +7.0% |
| Q4 2021 | $2,143,000 | +101.8% | 12,000 | +100.0% | 0.11% | +90.0% |
| Q3 2021 | $1,062,000 | +10.1% | 6,000 | 0.0% | 0.06% | +9.1% |
| Q2 2021 | $965,000 | +7.5% | 6,000 | 0.0% | 0.06% | +3.8% |
| Q1 2021 | $898,000 | +51.7% | 6,000 | 0.0% | 0.05% | +47.2% |
| Q4 2020 | $592,000 | – | 6,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |